2016 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015
DateTitle 
12/12/16Nuvectra Corporation Signs Direct Supply Agreement
Nuvectra Signs Direct Supply Agreement with Minnetronix, Inc. for External Devices PLANO, Texas, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced the completion of a direct supply agreement with Minnetronix, Inc., a Minnesota medical technology company. Nuvectra was previously purchasing the peripheral devices that were manufactured by Minnetronix through Integer Inc. (formerly known as Greatbatch), who acted a... 
Printer Friendly Version
11/21/16Nuvectra to Present at the 28th Annual Piper Jaffray Healthcare Conference
PLANO, Texas, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Financial Officer, are scheduled to present at the 28th Annual Piper Jaffray Healthcare Conference in New York, NY. Management will also be available for one-on-one meetings at the conference.    Event:   28th Annual Piper Jaffray Healthcare Conference ... 
Printer Friendly Version
11/09/16Nuvectra Reports Third Quarter 2016 Financial Results
Continued Progress Building U.S. Sales Organization and Market Awareness of Algovita® System PLANO, Texas, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the third quarter ended September 30, 2016. Highlights U.S. Algovita sales organization foundationally established, now covering 42 territories Virtis™ CE mark and FDA regulatory submission filings expected towards year end M... 
Printer Friendly Version
11/03/16Nuvectra to Present at 7th Annual Craig-Hallum Alpha Select Conference
PLANO, Texas, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Financial Officer, are scheduled to present at the 7th Annual Craig-Hallum Alpha Select Conference in New York, NY. Management will also be available for one-on-one meetings at the conference. Event:       7th Annual Craig-Hallum Alpha Select Conference Format:     Presentation and On... 
Printer Friendly Version
11/02/16Nuvectra to Report Third Quarter 2016 Financial Results on November 9, 2016
PLANO, Texas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the third quarter ended September 30, 2016 on Wednesday, November 9, 2016 after the market close. Nuvectra will hold a conference call on Wednesday, November 9, 2016 at 4:30pm ET to discuss the results. The dial in numbers are (844) 882-7830 for domestic callers and (574) 990-9704 for international calle... 
Printer Friendly Version
08/10/16Nuvectra Reports Second Quarter 2016 Financial Results
Accelerating U.S. Sales Team Build and Initiated Algovita® Sales in the U.S. PLANO, Texas, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended July 1, 2016. Recent Accomplishments & Highlights U.S. sales team now has 28 active territories with approximately 10 territories scheduled to complete training by the end of August Initiated U.S. sales of Algovita® S... 
Printer Friendly Version
08/08/16Nuvectra Announces Formation of Medical Advisory Board
PLANO, Texas, Aug. 08, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the formation of the Nuvectra Medical Advisory Board (“MAB”). The Nuvectra MAB is composed of three renowned experts in neurostimulation therapies and pain medicine. The MAB will serve as a key strategic resource for the Company as it commercializes the Algovita® Spinal Cord Stimulation System. The MAB will help guide the development of clinical study a... 
Printer Friendly Version
07/27/16Nuvectra to Report Second Quarter 2016 Financial Results on August 10, 2016
PLANO, Texas, July 27, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended July 1, 2016 on Wednesday, August 10, 2016 after the market close. Nuvectra will hold a conference call on Wednesday, August 10, 2016 at 4:30pm ET to discuss the results. The dial in numbers are (888) 514-4518 for domestic callers and (704) 815-5850 for international callers. The... 
Printer Friendly Version
06/28/16Nuvectra Added to the Russell Microcap® Index
PLANO, Texas, June 28, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it has been added to the Russell Microcap® Index. The addition occurred at the close of trading on June 24, 2016 when FTSE Russell reconstituted its comprehensive set of U.S. and global indexes. Membership in the Russell Microcap® Index, which remains in place for one year, provides automatic inclusion in the appropriate growth and value style i... 
Printer Friendly Version
05/27/16Aleva Neurotherapeutics Raises USD 18 Million in Series C Financing Round
... 
Printer Friendly Version
05/11/16Nuvectra Reports First Quarter 2016 Financial Results
PLANO, Texas, May 11, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended April 1, 2016. Recent Accomplishments & Highlights Completed spin-off from Greatbatch, Inc. on March 14, 2016 Initiated U.S. commercial launch of Algovita® Spinal Cord Stimulation System (“Algovita”) and first patients implanted in April 2016 Enhanced senior management team with the appointm... 
Printer Friendly Version
04/26/16Nuvectra to Report First Quarter 2016 Financial Results on May 11, 2016
PLANO, Texas, April 26, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended April 1, 2016, on Wednesday, May 11, 2016 after the market close. Nuvectra will hold a conference call on Wednesday, May 11, 2016 at 4:30 pm ET to discuss the results. The dial-in numbers are (888) 514-4518 for domestic callers and (704) 815-5850 for international callers. The co... 
Printer Friendly Version
04/11/16Nuvectra to Present at 15th Annual Needham Healthcare Conference
PLANO, Texas, April 11, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Financial Officer, are scheduled to present at the 15th Annual Needham Healthcare Conference in New York, NY.     Event: 15th Annual Needham Healthcare Conference Date: Wednesday, April 13, 2016 Time: 9:20 am ET ... 
Printer Friendly Version
04/07/16Nuvectra Corporation Appoints Paul Hanchin as Company President
Nuvectra Announces Changes to Executive Management Team PLANO, Texas, April 07, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced the appointment of Paul Hanchin in the newly created role of President, effective as of April 5, 2016. This new position will be responsible for global customer-facing activities for Nuvectra’s Spinal Cord Stimulation (SCS) business.  Mr. Hanchin will also be responsible for strategic planning an... 
Printer Friendly Version
03/14/16Nuvectra Corporation Begins Trading on NASDAQ
Spin-off from Greatbatch creates new stand-alone neurostimulation company PLANO, Texas, March 14, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), formerly QIG Group, LLC, announced today the completion of its spin-off from Greatbatch, Inc. (NYSE:GB) into an independent, publicly-traded neurostimulation medical device company. Nuvectra shares commenced “regular way” trading today on the NASDAQ Global Market (NASDAQ) under the symbol “NVTR”. The spinoff was accomplished by the d... 
Printer Friendly Version
02/24/16Greatbatch’s Board of Directors Declares Spin-off Dividend of the Nuvectra Shares
Sets Record Date of March 7, 2016 and Nuvectra Share Distribution Date of March 14, 2016 FRISCO, Texas, Feb. 24, 2016 (GLOBE NEWSWIRE) -- Greatbatch, Inc. (NYSE:GB) today announced that its Board of Directors has approved the spin-off of QiG Group, LLC, which will convert into Nuvectra Corporation prior to the completion of the spin-off (“Nuvectra”), in the form of a tax-free pro rata dividend involving the distribution of all of the outstanding shares of Nuvec... 
Printer Friendly Version
02/01/16Aleva Neurotherapeutics and Greatbatch Collaborate on Next-Generation Device for Deep Brain Stimulation (DBS)
Agreement Includes Strategic Investment in Aleva’s Current Series C Round by GreatbatchLAUSANNE, Switzerland, Feb. 01, 2016 (GLOBE NEWSWIRE) -- Aleva Neurotherapeutics, a leading company developing next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s disease and essential tremor, today announced a strategic development, supply, and manufacturing relationship with Greatbatch Ltd., a subsidiary of Greatbatch, Inc.&... 
Printer Friendly Version